OBJECTIVES: The Tack implant is designed for focal, minimal metal management of dissections. This study evaluated Tacks for treating postpercutaneous transluminal angioplasty (PTA) dissection in patients with below-the-knee (BTK) arterial occlusive disease. BACKGROUND: PTA is the most commonly used endovascular treatment for patients with occlusive disease of the BTK vessels. Post-PTA dissection is a significant clinical problem that results in poor outcomes, but currently there are limited treatment options for managing dissections. METHODS: This prospective, single-arm study evaluated patients with CLI and BTK lesions; 11.4% were Rutherford category (RC) 4 and 88.6% were RC 5. BTK occlusive disease was treated with standard PTA and post-PTA dissections were treated with Tack placement. The primary safety endpoint was a composite of major adverse limb events (MALE) and perioperative death (POD) at 30 days. Other endpoints included: device success; procedure success (vessel patency in the absence of MALE); freedom from clinically driven target lesion revascularization (CD-TLR); primary patency; and changes in RC. Data through 12 months are presented. RESULTS: Thirty-two of 35 (91.4%) patients had post-PTA dissection and successful deployment of Tacks. Procedural success was achieved in 34/35 (97.1%) patients with no MALEs at 30 days. The 12-month patency rate was 78.4% by vessel, 77.4% by patient, and freedom from CD-TLR was 93.5%. Significant (P < .0001) improvement from baseline was observed in RC (75% of patients improved 4 or 5 steps). CONCLUSION: Tack implant treatment of post-PTA dissection was safe and effective for treatment of BTK dissections and resulted in reasonable 12-month patency and low rates of CD-TLR.

Auckland City Hospital Auckland New Zealand

Kaiser Permanente Honolulu Hawaii

Klinische Abteilung für Angiologie Medizinische Universtitätsklinik Graz Austria

St Anne's University Hospital and Faculty of Medicine Masaryk University Brno Czech Republic

Universitäts Herzzentrum Bad Krozingen Germany

Waikato Hospital Hamilton New Zealand

Westküstenklinikum Heide Germany

Zobrazit více v PubMed

Allie DE, Hebert CJ, Lirtzman MD, et al. Critical limb ischemia: A global epidemic. A critical analysis of current treatment unmasks the clinical and economic costs of CLI. EuroIntervention 2005;1:75–84. PubMed

Albers M, Romiti M, Brochado‐Neto FC, De Luccia N, Pereira CAB. Meta‐analysis of popliteal‐to‐distal vein bypass grafts for critical ischemia. J Vasc Surg 2006;43:498. PubMed

Romiti M, Albers M, Brochado‐Neto FC, Durazzo AES, Pereira CAB, De Luccia N. Meta‐analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008;47:20–22. PubMed

Bisdas T, Borowski M, Stavroulakis K, Torsello G, Adili F, Balzer K, Billing A, Böckler D, Brixner D, Debus SE, Eckstein H‐H, Florek H‐J, Gkremoutis A, Grundmann R, Hupp T, Keck T, Gerß J, Klonek W, Lang W, May B, Meyer A, Mühling B, Oberhuber A, Reinecke H, Reinhold C, Ritter R‐G, Schelzig H, Schlensack C, Schmitz‐Rixen T, Schulte K‐L, Spohn M, Steinbauer M, Storck M, Trede M, Uhl C, Weis‐Müller B, Wenk H, Zeller T, Zhorzel S, Zimmermann A. Endovascular therapy versus bypass surgery as first‐line treatment strategies for critical limb ischemia: Results of the interim analysis of the CRITISCH registry. J Am Coll Cardiol Intv 2016;9:2557–2565. PubMed

Atar E, Siegel Y, Avrahami R, Bartal G, Bachar GN, Belenky A. Balloon angioplasty of popliteal and crural arteries in elderly with critical chronic limb ischemia. Eur J Radiol 2005;53:287–292. PubMed

Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879–1888. PubMed

Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte K‐L, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tübler T, Zeller T. Transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: The femoral artery stenting trial (FAST). Circulation 2007;116:285–292. PubMed

Bosiers M, Torsello G, Gissler H‐M, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12‐month results of the DURABILITY I study. J Endovasc Ther 2009;16:261–269. PubMed

Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve‐month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010;3:267–276. PubMed

Feiring AJ, Krahn M, Nelson L, Wesolowski A, Eastwood D, Szabo A. Preventing leg amputations in critical limb ischemia with below‐the‐knee drug‐eluting stents. J Am Coll Cardiol 2010;55:1580–1589. PubMed

Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Christeas N, Kagadis GC. Infrapopliteal application of paclitaxel‐eluting stents for critical limb ischemia: Midterm angiographie and clinical results. J Vasc Interv Radiol 2007;18:1351–1361. PubMed

Siablis D, Karnabatidis D, Katsanos K. Infrapopliteal application of sirolimus‐eluting versus bare metal stents for critical limb ischemia: Analysis of long‐term angiographic and clinical outcome. J Vasc Interv Radiol 2009;20:1141–1150. PubMed

Scheinert D, Katsanos K, Zeller T, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus‐eluting stent in patients with ischemic peripheral arterial disease. J Am Coll Cardiol 2012;60:2290–2295. PubMed

Bosiers M, Scheinert D, Hendriks JMH, et al. Results from the tack optimized balloon angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty. J Vasc Surg 2016;64:109–116. PubMed

Anon . Coronary artery angiographic changes after PTCA: In: Manual of Operations NHLBI PTCA Registry; 1985:6–9.

Peregrin JH, Šmírová S, Kožnar B, et al. Self‐expandable stent placement in infrapopliteal arteries after unsuccessful angioplasty failure: One‐year follow‐up. Cardiovasc Intervent Radiol 2008;31:860–864. PubMed

Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation 1992;86:64–70. PubMed

Nelken N, Schneider PA. Advances in stent technology and drug‐eluting stents. Surg Clin North Am 2004;84:1203–1236. PubMed

Cha S‐H, Han MH, Choi YH, et al. Vascular responses in normal canine carotid arteries: Comparison between various self‐expanding stents of the same unconstrained size. Invest Radiol 2003;38:95–101. PubMed

Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Pathological correlates of late drug‐eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007;115:2435–2441. PubMed

van Beusekom HMM, Whelan DM, Hofma SH, Krabbendam SC, van Hinsbergh VWM, Verdouw PD, van der Giessen WJ. Long‐term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. J Am Coll Cardiol 1998;32:1109–1117. PubMed

Lau K‐W, Mak K‐H, Hung J‐S, Sigwart U. Clinical impact of stent construction and design in percutaneous coronary intervention. Am Heart J 2004;147:764–773. PubMed

Hara H, Nakamura M, Palmaz JC, Schwartz RS. Role of stent design and coatings on restenosis and thrombosis. Adv Drug Deliv Rev 2006;58:377–386. PubMed

Morton AC, Crossman D, Gunn J. The influence of physical stent parameters upon restenosis. Pathol Biol (Paris) 2004;52:196–205. PubMed

Scheinert D, Scheinert S, Sax J, Piorkowski C, Bräunlich S, Ulrich M, Biamino G, Schmidt A. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312–315. PubMed

Duda SH, Bosiers M, Lammer J, et al. Drug‐eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: Long‐term results from the SIROCCO trial. J Endovasc Ther 2006;13:701–710. PubMed

Dake MD, Ansel GM, Jaff MR, et al. Paclitaxel‐eluting stents show superiority to balloon angioplasty and bare metal stents in twelve‐month zilver PTX randomized study results. Circ Cardiovasc Interv 2011;4:495–504. PubMed

Tepe G, Zeller T, Schnorr B, Claussen CD, Beschorner U, Brechtel K, Scheller B, Speck U. High‐grade, non‐flow‐limiting dissections do not negatively impact long‐term outcome after paclitaxel‐coated balloon angioplasty: An additional analysis from the THUNDER study. J Endovasc Ther 2013;20:792–800. PubMed